Sign in Subscribe
Pharmaceutical industry

Stocks in the Drugs Industry Take a Hit

Strategic Insights

— 1 min read

The Drugs industry is experiencing a downturn, with all three major indices showing a decline. As of Friday, Dec. 18, 2015, at 11:55 AM ET, the Dow Jones Industrial Average is down 230 points, or 1.3%, at 17,266. The NYSE advances/declines ratio is 1,238 issues advancing vs. 1,715 declining, with 142 issues unchanged. The Drugs industry is down 0.8%, with top decliners including Valeant Pharmaceuticals International, Bristol-Myers Squibb Company, and Abbott Laboratories.

Key Takeaways:

  • The Dow Jones Industrial Average is trading down 230 points, or 1.3%, at 17,266 as of Friday, Dec. 18, 2015, 11:55 AM ET.
  • The Drugs industry is down 0.8%, with a market cap of $85.4 billion.
  • Top decliners in the Drugs industry include Valeant Pharmaceuticals International, down 2.0%, Bristol-Myers Squibb Company, down 1.8%, and Abbott Laboratories, down 1.6%.
  • AstraZeneca PLC is one of the companies pushing the Drugs industry lower, down $0.45 (-1.4%) to $32.91 on average volume.
  • Johnson & Johnson is down $0.91 (-0.9%) to $102.73 on average volume, with 4.9 million shares exchanged hands.
  • Gilead Sciences, Inc. is down $0.81 (-0.8%) to $101.55 on average volume, with 4.4 million shares exchanged hands.
  • TheStreet Ratings rates AstraZeneca as a buy, with a compelling growth in net income, largely solid financial position, expanding profit margins, and notable return on equity.
  • TheStreet Ratings rates Johnson & Johnson as a buy, with a largely solid financial position, reasonable valuation levels, good cash flow from operations, and expanding profit margins.
  • TheStreet Ratings rates Gilead as a buy, with robust revenue growth, notable return on equity, attractive valuation levels, expanding profit margins, and good cash flow from operations.

Statistics:

  • The Dow Jones Industrial Average is down 230 points, or 1.3%, at 17,266 as of Friday, Dec. 18, 2015, 11:55 AM ET.
  • The Drugs industry is down 0.8% with a market cap of $85.4 billion.
  • Top decliners in the Drugs industry include:

+ Valeant Pharmaceuticals International: down 2.0%

+ Bristol-Myers Squibb Company: down 1.8%

+ Abbott Laboratories: down 1.6%

+ Merck: down 0.9%

+ Shire: down 0.8%

  • Top gainers in the Drugs industry include:

+ Mylan: up 0.8%

  • TheStreet Ratings rates:

+ AstraZeneca: buy

+ Johnson & Johnson: buy

+ Gilead Sciences, Inc.: buy

Sources:

  • TheStreet Wire
  • Yahoo Finance
  • Thomson Reuters
  • TheStreet Ratings
  • MarketWatch

Read more